Comparing two biochemical markers prokineticin-2 and procalcitonin for predicting the outcome of infection in patients admitted in IC
Not Applicable
- Conditions
- Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/07/044337
- Lead Sponsor
- All India Institute of Medical Sciences Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having clinical features suggestive of sepsis as defined by Sepsis-3 definition (2016) at the time of ICU admission
Exclusion Criteria
Patients/ relatives who refused to give informed consent.
Age less than 18 years.
Patients with terminal stage of disease (malignancy , Acquired immunodeficiency Syndrome, end stage liver or renal disease).
HIV/HBSAG/HCV .
Autoimmune disorders/ metabolic diseases. On long term steroids/ immunosuppressants/ chemotherapy
Osteoarthritis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method